Biodegradable polymers for targeted delivery of anti-cancer drugs

Expert Opinion on Drug Delivery

Volumn 13, Issue 6, 2016, Pages 891-909

  Doppalapudi, Sindhu ^a   Jain, Anjali ^a   Domb, Abraham J ^b   Khan, Wahid ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Biodegradable polymers; chemotherapeutics; controlled release; intratumoral delivery; polymeric carriers; targeting

Indexed keywords

2 HYDROXYACID; ACID ANHYDRIDE; ALGINIC ACID; AMINO ACID DERIVATIVE; ANTINEOPLASTIC AGENT; CARBONIC ACID DERIVATIVE; CELLULOSE; CHITOSAN; CHONDROITIN SULFATE; COLLAGEN; CYANOACRYLATE DERIVATIVE; GELATIN; HYALURONIC ACID; LACTONE DERIVATIVE; ORGANOPHOSPHATE; POLY(ORTHO ESTER); POLYGLUTAMIC ACID; POLYHYDROXYALKANOIC ACID; POLYMER; STARCH; URETHAN DERIVATIVE; DRUG CARRIER;

DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG TARGETING; HUMAN; POLYMERIZATION; REVIEW; CHEMISTRY; NEOPLASMS;

ANTINEOPLASTIC AGENTS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; NEOPLASMS; POLYMERS;

EID: 84961210141     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2016.1156671     Document Type: Review

References (128)

1. D.Liu, D.T.Auguste Cancer targeted therapeutics: From molecules to drug delivery vehicles. J Control Release. 2015;219:632–643. doi:10.1016/j.jconrel.2015.08.041.•• This paper provides focus on the systemic administration of anti-cancer agents and an update on timeline of progress in targeted cancer therapy.
2. I.K.Kwon, S.C.Lee, B.Han, et al. Analysis on the current status of targeted drug delivery to tumors. J Control Release. 2012;164(2):108–14.
3. F.Danhier, O.Feron, V.Préat. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release. 2010;148(2):135–146. doi:10.1016/j.jconrel.2010.08.027.•• This paper provides good understanding on design of targeted drug delivery systems by exploiting tumor microenvironment.
4. D.H.Lewis. Controlled release of bioactive agents from lactide/glycolide polymers. Biodegradable polymers as drug delivery systems, drugs and pharmaceutical sciences. New York: Marcel Dekker; 1990. p. 1–41.
5. M.Schlechter Biodegradable polymers (PLS025D); 2011 [cited 2011 May]. Available from: http://www.bccresearch.com/market-research/plastics/biodegradable-polymers-market-pls025d.html
6. M.F.Oliveira, P.P.G.Guimaraes, A.D.M.Gomes, et al. Strategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and market. J Chem Biology. 2013;6(1):7–23. doi:10.1007/s12154-012-0086-x.• This paper gives review on biodegradable polymer based nanodelivery systems for targeting tumors.
7. Y.H.Bae, K.Park. Targeted drug delivery to tumors: myths, reality and possibility. J Control Release. 2011;153(3):198. doi:10.1016/j.jconrel.2011.06.003.•• This paper provides a perspective on variety of issues and factors related to the development of targeted drug delivery systems.
8. R.H.Prabhu, V.B.Patravale, M.D.Joshi. Polymeric nanoparticles for targeted treatment in oncology: current insights. Int J Nanomedicine. 2015;10:1001.• This paper provides insights on advances in field of targeted nanocarriers in oncology.
9. J.B.Wolinsky, Y.L.Colson, M.W.Grinstaff. Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. J Control Release. 2012;159(1):14–26. doi:10.1016/j.jconrel.2011.11.031.•• This paper describes various local polymer delivery systems in cancer and technical hurdles in their development.
10. J.P.Jain, W.Yenet Ayen, A.J.Domb, et al. Biodegradable polymers in drug delivery. Biodegradable polymers in clinical use and clinical development. New York: John Wiley & Sons; 2011. p. 1–58.
11. A.K.Jain, M.Das, N.K.Swarnakar, et al. Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics. Crit Rev Ther Drug Carrier Syst. 2011;28(1):1–45.
12. K.K.Jain. Targeted drug delivery for cancer. Technol Cancer Res Treat. 2005;4:311–313.
13. S.Dhar, F.X.Gu, R.Langer, et al. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt (IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci. 2008;105(45):17356–17361. doi:10.1073/pnas.0809154105.
14. H.Wang, Y.Zhao, Y.Wu, et al. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials. 2011;32:8281–8290. doi:10.1016/j.biomaterials.2011.07.032.
15. S.Doppalapudi, A.Jain, W.Khan, et al. Biodegradable polymers-an overview. Polymer Adv Tech. 2014;25(5):427–435. doi:10.1002/pat.3305.
16. N.Zhou, X.Zan, Z.Wang, et al. Galactosylated chitosan-polycaprolactone nanoparticles for hepatocyte-targeted delivery of curcumin. Carbohydr Polym. 2013;94(1):420–429. doi:10.1016/j.carbpol.2013.01.014.
17. Y.Li, K.Xiao, W.Zhu, et al. Stimuli-responsive cross-linked micelles for on-demand drug delivery against cancers. Adv Drug Deliv Rev. 2014;66:58–73. doi:10.1016/j.addr.2013.09.008.
18. P.Huang, C.Yang, J.Liu, et al. Improving the oral delivery efficiency of anticancer drugs by chitosan coated polycaprolactone-grafted hyaluronic acid nanoparticles. J Mater Chem B. 2014;2(25):4021–4033. doi:10.1039/C4TB00273C.
19. C.Varan, E.Bilensoy. Development of implantable hydroxypropyl-β-cyclodextrin coated polycaprolactone nanoparticles for the controlled delivery of docetaxel to solid tumors. J Incl Phenom Macrocycl Chem. 2014;80(1–2):9–15. doi:10.1007/s10847-014-0422-6.
20. J.Liu, Z.Jiang, S.Zhang, et al. Biodegradation, biocompatibility, and drug delivery in poly (ω-pentadecalactone-co-p-dioxanone) copolyesters. Biomaterials. 2011;32(27):6646–6654. doi:10.1016/j.biomaterials.2011.05.046.
21. S.Binauld, M.H.Stenzel. Acid-degradable polymers for drug delivery: a decade of innovation. Chem Commun. 2013;49(21):2082–2102. doi:10.1039/c2cc36589h.
22. Z.Yuan, J.Huang, J.Liu, et al. PEG-detachable and acid-labile cross-linked micelles based on orthoester linked graft copolymer for paclitaxel release. Nanotechnology. 2011;33(22):335601. doi:10.1088/0957-4484/22/33/335601.
23. T.Steinbach, F.R.Wurm. Poly (phosphoester) s: A New Platform for Degradable Polymers. Angew Chem Int Ed. 2015;54(21):6098–6108. doi:10.1002/anie.201500147.
24. C.-Y.Sun, S.Dou, J.Z.Du, et al. Doxorubicin Conjugate of Poly (Ethylene Glycol)-Block-Polyphosphoester for Cancer Therapy. Adv Healthc Mater. 2014;3(2):261–272. doi:10.1002/adhm.201300091.
25. Y.Tao, J.He, M.Zhang, et al. Galactosylated biodegradable poly (ε-caprolactone-co-phosphoester) random copolymer nanoparticles for potent hepatoma-targeting delivery of doxorubicin. Polym Chem. 2014;5(10):3443–3452. doi:10.1039/c4py00024b.
26. A.B.E.Attia, P.Oh, C.Yang, et al. Insights into EPR Effect versus Lectin-mediated Targeted Delivery: Biodegradable Polycarbonate Micellar Nanoparticles with and without Galactose Surface Decoration. Small. 2014;10(21):4281–4286. doi:10.1002/smll.201401295.
27. H.Wang, Y.Wang, Y.Chen, et al. A biomimic pH-sensitive polymeric prodrug based on polycarbonate for intracellular drug delivery. Polym Chem. 2014;5(3):854–861. doi:10.1039/C3PY00861D.
28. X.Y.Ke, V.W.L.Ng, S.J.Gao, et al. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells. Biomaterials. 2014;35(3):1096–1108. doi:10.1016/j.biomaterials.2013.10.049.
29. A.Domb, J.P.Jain, N.Kumar. Polyanhydrides. Handbook of Biodegradable Polymers: Isolation, Synthesis, Characterization and Applications. Weinheim: Wiley-VCH;2011. p. 45–75.
30. A.J.Domb, W.Khan. Biodegradable polymers as drug carrier systems. Polymeric Biomaterials: Structure and Function. New York: Marcel Dekker; 2013. p. 135.
31. J.Wang, G.Yang, X.Guo, et al. Redox-responsive polyanhydride micelles for cancer therapy. Biomaterials. 2014;35(9):3080–3090. doi:10.1016/j.biomaterials.2013.12.025.
32. F.Jia, X.Liu, L.Li, et al. Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents. J Control Release. 2013;172(3):1020–1034. doi:10.1016/j.jconrel.2013.10.012.
33. A.J.Domb, Z.H.Israel, O.Elmalak, et al. Preparation and characterization of carmustine loaded polyanhydride wafers for treating brain tumors. Pharmaceut Res. 1999;16(5):762–765. doi:10.1023/A:1011995728760.
34. J.P.Jain, S.Modi, A.J.Domb, et al. Role of polyanhydrides as localized drug carriers. J Control Release. 2005;103(3):541–563. doi:10.1016/j.jconrel.2004.12.021.
35. E.Levy-Nissenbaum, W.Khan, R.P.Pawar, et al. Pharmacokinetic and efficacy study of cisplatin and paclitaxel formulated in a new injectable poly (sebacic-co-ricinoleic acid) polymer. Eur J Pharm Biopharm. 2012;82(1):85–93. doi:10.1016/j.ejpb.2012.06.004.
36. J.Y.Cherng, T.Y.Hou, M.F.Shih, et al. Polyurethane-based drug delivery systems. Int J Pharm. 2013;450(1):145–162. doi:10.1016/j.ijpharm.2013.04.063.
37. M.Ding, N.Song, X.He, et al. Toward the next-generation nanomedicines: design of multifunctional multiblock polyurethanes for effective cancer treatment. ACS Nano. 2013;7(3):1918–1928. doi:10.1021/nn4002769.
38. S.Yu, J.Ding, C.He, et al. Disulfide Cross-Linked Polyurethane Micelles as a Reduction Triggered Drug Delivery System for Cancer Therapy. Adv Healthc Mater. 2014;3(5):752–760. doi:10.1002/adhm.201300308.
39. C.Chun, S.M.Lee, C.W.Kim, et al. Doxorubicin-polyphosphazene conjugate hydrogels for locally controlled delivery of cancer therapeutics. Biomaterials. 2009;30(27):4752–4762. doi:10.1016/j.biomaterials.2009.05.031.
40. C.Zheng, L.Qiu, K.Zhu. Novel polymersomes based on amphiphilic graft polyphosphazenes and their encapsulation of water-soluble anti-cancer drug. Polymer. 2009;50(5):1173–1177. doi:10.1016/j.polymer.2009.01.004.
41. J.Xu, Q.Zhao, Y.Jin, et al. High loading of hydrophilic/hydrophobic doxorubicin into polyphosphazene polymersome for breast cancer therapy. Nanomed Nanotech Biol Med. 2014;10(2):349–358. doi:10.1016/j.nano.2013.08.004.
42. L.Qiu, C.Zheng, Q.Zhao. Mechanisms of drug resistance reversal in Dox-resistant MCF-7 cells by pH-responsive amphiphilic polyphosphazene containing diisopropylamino side groups. Mol Pharm. 2012;9(5):1109–1117. doi:10.1021/mp200356w.
43. I.Teasdale, S.Wilfert, I.Nischang, et al. Multifunctional and biodegradable polyphosphazenes for use as macromolecular anti-cancer drug carriers. Polym Chem. 2011;2(4):828–834. doi:10.1039/C0PY00321B.
44. J.Nicolas, P.Couvreur. Synthesis of poly (alkyl cyanoacrylate)-based colloidal nanomedicines. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009;1:111–127. doi:10.1002/wnan.15.
45. M.Dossi, G.Storti, D.Moscatelli. Synthesis of poly (alkyl cyanoacrylates) as biodegradable polymers for drug delivery applications. Macromol Symp. 2010;289(1):124–128. doi:10.1002/masy.v289:1.
46. J.Duan, M.Liu, Y.Zhang, et al. Folate-decorated chitosan/doxorubicin poly (butyl) cyanoacrylate nanoparticles for tumor-targeted drug delivery. J Nanopart Res. 2012;14(4):1–9. doi:10.1007/s11051-011-0686-3.
47. J.Nicolas, D.Brambilla, O.Carion, et al. Quantum dot-loaded PEGylated poly (alkyl cyanoacrylate) nanoparticles for in vitro and in vivo imaging. Soft Matter. 2011;7(13):6187–6193. doi:10.1039/c1sm05529a.
48. J.W.Singer. Paclitaxel poliglumex (XYOTAX, CT-2103): a macromolecular taxane. J Control Release. 2005;109(1):120–126. doi:10.1016/j.jconrel.2005.09.033.
49. S.Doppalapudi, S.Katiyar, A.J.Domb, et al. Biodegradable Natural Polymers. Advanced Polymers in Medicine. Cham: Springer International Publishing; 2015. p. 33–66.
50. L.Dai, T.Yang, J.He, et al. Cellulose-graft-poly (L-lactic acid) nanoparticles for efficient delivery of anti-cancer drugs. J Mater Chem B. 2014;2(39):6749–6757. doi:10.1039/C4TB00956H.
51. B.Sivakumar, R.G.Aswathy, Y.Nagaoka, et al. Multifunctional carboxymethyl cellulose-based magnetic nanovector as a theragnostic system for folate receptor targeted chemotherapy, imaging, and hyperthermia against cancer. Langmuir. 2013;29(10):3453–3466. doi:10.1021/la305048m.
52. G.Baier, D.Baumann, J.M.Siebert, et al. Suppressing unspecific cell uptake for targeted delivery using hydroxyethyl starch nanocapsules. Biomacromolecules. 2012;13(9):2704–2715. doi:10.1021/bm300653v.
53. A.Zhang, Z.Zhang, F.Shi, et al. Disulfide crosslinked PEGylated starch micelles as efficient intracellular drug delivery platforms. Soft Matter. 2013;9(7):2224–2233. doi:10.1039/c2sm27189c.
54. Y.Cheng, S.Yu, X.Zhen, et al. Alginic acid nanoparticles prepared through counterion complexation method as a drug delivery system. ACS Appl Mater Interfaces. 2012;4(10):5325–5332. doi:10.1021/am3012627.
55. H.Cai, C.Ni, L.Zhang. Preparation of complex nano-particles based on alginic acid/poly [(2-dimethylamino) ethyl methacrylate] and a drug vehicle for doxorubicin release controlled by ionic strength. Eur J Pharm Sci. 2012;45(1):43–49. doi:10.1016/j.ejps.2011.10.020.
56. D.Vergara, C.Bellomo, X.Zhang, et al. Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer. Nanomed Nanotech Biol Med. 2012;8(6):891–899. doi:10.1016/j.nano.2011.10.014.
57. A.Anitha, K.P.Chennazhi, S.V.Nair, et al. 5-flourouracil loaded N, O-carboxymethyl chitosan nanoparticles as an anticancer nanomedicine for breast cancer. J Biomed Nanotechnol. 2012;8(1):29–42.
58. D.Jiang, L.S.Mangala, H.Wang, et al. Tumor vasculature targeting using cell-specific thioaptamer decorated chitosan nanoparticle. Cancer Res. 2014;74(19):4468. doi:10.1158/0008-5472.CAN-13-3514.
59. 4/chitosan nanocomposite for magnetic drug targeting to cancer. J Mater Chem B. 2012;22(15):7622–7632. doi:10.1039/c2jm15339d.
60. K.H.Bae, M.Park, M.J.Do, et al. Chitosan oligosaccharide-stabilized ferrimagnetic iron oxide nanocubes for magnetically modulated cancer hyperthermia. ACS Nano. 2012;6:5266–5273. doi:10.1021/nn301046w.
61. K.Y.Choi, G.Saravanakumar, J.H.Park, et al. Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer. Colloids Surf B. 2012;99:82–94. doi:10.1016/j.colsurfb.2011.10.029.
62. K.Y.Choi, H.Y.Yoon, J.-H.Kim, et al. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy. ACS Nano. 2011;5(11):8591–8599. doi:10.1021/nn202070n.
63. K.Y.Choi, E.J.Jeon, H.Y.Yoon, et al. Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer. Biomaterials. 2012;33(26):6186–6193. doi:10.1016/j.biomaterials.2012.05.029.
64. J.H.Park, H.J.Cho, H.Y.Yoon, et al. Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery. J Control Release. 2014;174:98–108. doi:10.1016/j.jconrel.2013.11.016.
65. M.Ferro, G.Giuberti, S.Zappavigna, et al. Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms. Oncol Rep. 2012;27(2):409–415. doi:10.3892/or.2011.1526.
66. S.Maya, B.Sarmento, A.Nair, et al. Smart stimuli sensitive nanogels in cancer drug delivery and imaging: a review. Curr Pharm Des. 2013;19(41):7203–7218.
67. J.Y.Lee, S.J.Chung, H.J.Cho, et al. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery. Eur J Pharm Biopharm. 2015;94:532–541. doi:10.1016/j.ejpb.2015.06.011.
68. C.Yu, C.Gao, S.Lu, et al. Facile preparation of pH-sensitive micelles self-assembled from amphiphilic chondroitin sulfate-histamine conjugate for triggered intracellular drug release. Colloids Surf B Biointerfaces. 2014;115:331–339. doi:10.1016/j.colsurfb.2013.12.023.
69. C.Kojima, T.Suehiro, K.Watanabe, et al. Doxorubicin-conjugated dendrimer/collagen hybrid gels for metastasis-associated drug delivery systems. Acta Biomater. 2013;9(3):5673–5680. doi:10.1016/j.actbio.2012.11.013.
70. K.Watanabe, Y.Nishio, R.Makiura, et al. Paclitaxel-loaded hydroxyapatite/collagen hybrid gels as drug delivery systems for metastatic cancer cells. Int J Pharm. 2013;446(1):81–86. doi:10.1016/j.ijpharm.2013.02.002.
71. J.Xu, A.Singh, M.M.Amiji. Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer. BMC Cancer. 2014;14(1):75. doi:10.1186/1471-2407-14-75.
72. T.S.Anirudhan, A.M.Mohan. Novel pH switchable gelatin based hydrogel for the controlled delivery of the anti cancer drug 5-fluorouracil. RSC Adv. 2014;4(24):12109–12118. doi:10.1039/c3ra47991a.
73. B.Elsadek, F.Kratz. Impact of albumin on drug delivery - New applications on the horizon. J Control Release. 2012;157(1):4–28. doi:10.1016/j.jconrel.2011.09.069.
74. A.O.Elzoghby, W.M.Samy, N.A.Elgindy. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release. 2012;157(2):168–182. doi:10.1016/j.jconrel.2011.07.031.
75. Y.-R.Zheng, K.Suntharalingam, T.C.Johnstone, et al. Pt (IV) prodrugs designed to bind non-covalently to human serum albumin for drug delivery. J Am Chem Soc. 2014;136(24):8790–8798. doi:10.1021/ja5038269.
76. C.A.Schutz, L.Juillerat-Jeanneret, H.Mueller, et al. Therapeutic nanoparticles in clinics and under clinical evaluation. Nanomedicine. 2013;8(3):449–467. doi:10.2217/nnm.13.8.•• This paper provides an extensive review on nanoparticulate chemotherapeutic systems in clinical trials and under preclinical development.
77. R.Nigmatullin, P.Thomas, B.Lukasiewicz, et al. Polyhydroxyalkanoates, a family of natural polymers, and their applications in drug delivery. J Chem Technol Biotechnol. 2015;90(7):1209–1221. doi:10.1002/jctb.4685.
78. M.Shah, N.Ullah, M.H.Choi, et al. Nanoscale Poly (4-hydroxybutyrate)-mPEG Carriers for Anticancer Drugs Delivery. J Nanosci Nanotechnol. 2014;14(11):8416–8421.
79. S.Yalcin, G.Unsoy, P.Mutlu, et al. Polyhydroxybutyrate-Coated Magnetic Nanoparticles for Doxorubicin Delivery: Cytotoxic Effect Against Doxorubicin-Resistant Breast Cancer Cell Line. Am J Ther. 2014;21(6):453–461. doi:10.1097/MJT.0000000000000066.
80. A.Ogunleye, A.Bhat, V.U.Irorere, et al. Poly-γ-glutamic acid: production, properties and applications. Microbiology. 2015;161(Pt 1):1–17. doi:10.1099/mic.0.081448-0.
81. A.Seth, M.B.Heo, Y.T.Lim. Poly (γ-glutamic acid) based combination of water-insoluble paclitaxel and TLR7 agonist for chemo-immunotherapy. Biomaterials. 2014;35(27):7992–01. doi:10.1016/j.biomaterials.2014.05.076.
82. M.Li, W.Song, Z.Tang, et al. Nanoscaled poly (L-glutamic acid)/doxorubicin-amphiphile complex as pH-responsive drug delivery system for effective treatment of nonsmall cell lung cancer. ACS Appl Mater Interfaces. 2013;5:1781–1792. doi:10.1021/am303073u.
83. S.Maya, B.Sarmento, V.-K.Lakshmanan, et al. Actively targeted cetuximab conjugated-Poly (glutamic acid)-docetaxel nanomedicines for epidermal growth factor receptor over expressing colon cancer cells. J Biomed Nanotechnol. 2014;10(8):1416–1428.
84. M.Pachauri, E.D.Gupta, P.C.Ghosh. Piperine loaded PEG-PLGA nanoparticles: Preparation, characterization and targeted delivery for adjuvant breast cancer chemotherapy. J Drug Deliv Sci Technol. 2015;29:269–282. doi:10.1016/j.jddst.2015.08.009.
85. A.Kumar, K.Sawant. Encapsulation of exemestane in polycaprolactone nanoparticles: optimization, characterization, and release kinetics. Cancer Nanotechnol. 2013;4(4–5):57–71. doi:10.1007/s12645-013-0037-4.
86. E.M.Alexandrino, S.Ritz, F.Marsico, et al. Paclitaxel-loaded polyphosphate nanoparticles: a potential strategy for bone cancer treatment. J Mater Chem B. 2014;2(10):1298–1306. doi:10.1039/c3tb21295e.
87. S.W.Kang, Y.Li, J.H.Park, et al. pH-triggered unimer/vesicle-transformable and biodegradable polymersomes based on PEG-b-PCL-grafted poly (β-amino ester) for anti-cancer drug delivery. Polymer. 2013;54(1):102–110. doi:10.1016/j.polymer.2012.10.055.
88. H.Oliveira, E.Pérez-Andrés, J.Thevenot, et al. Magnetic field triggered drug release from polymersomes for cancer therapeutics. J Control Release. 2013;169(3):165–170. doi:10.1016/j.jconrel.2013.01.013.
89. N.Sood, W.T.Jenkins, X.-Y.Yang, et al. Biodegradable Polymersomes for the Delivery of Gemcitabine to Panc-1 Cells. J Pharmaceutics. 2013;2013. doi:10.1155/2013/932797.
90. Z.Pang, H.Gao, Y.Yu, et al. Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin. Bioconjugate Chem. 2011;22(6):1171–1180. doi:10.1021/bc200062q.
91. H.E.Colley, V.Hearnden, M.Avila-Olias, et al. Polymersome-mediated delivery of combination anticancer therapy to head and neck cancer cells: 2D and 3D in vitro evaluation. Mol Pharm. 2014;11(4):1176–1188. doi:10.1021/mp400610b.
92. L.M.Kaminskas, V.M.McLeod, G.M.Ryan, et al. Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy. J Control Release. 2014;183:18–26. doi:10.1016/j.jconrel.2014.03.012.
93. C.H.Huang, K.Nwe, A.Al Zaki, et al. Biodegradable polydisulfide dendrimer nanoclusters as MRI contrast agents. ACS Nano. 2012;6(11):9416–9424. doi:10.1021/nn304160p.
94. Z.Sideratou, C.Kontoyianni, G.I.Drossopoulou, et al. Synthesis of a folate functionalized PEGylated poly (propylene imine) dendrimer as prospective targeted drug delivery system. Bioorg Med Chem Lett. 2010;20(22):6513–6517. doi:10.1016/j.bmcl.2010.09.058.
95. K.Jain, U.Gupta, N.K.Jain. Dendronized nanoconjugates of lysine and folate for treatment of cancer. Eur J Pharm Biopharm. 2014;87(3):500–509. doi:10.1016/j.ejpb.2014.03.015.
96. C.Zhang, D.Pan, K.Luo, et al. Peptide Dendrimer-Doxorubicin Conjugate-Based Nanoparticles as an Enzyme Responsive Drug Delivery System for Cancer Therapy. Adv Healthc Mater. 2014;3(8):1299–1308. doi:10.1002/adhm.201300601.
97. R.Satchi-Fainaro, R.Duncan, C.M.Barnes. Polymer therapeutics for cancer: current status and future challenges. Polymer Therapeutics II. Heidelberg: Springer; 2006. p. 1–65.•• This paper provides a comprehensive review on polymer therapeutics, which are under clinical evaluation for cancer therapy.
98. P.Zhao, H.Wang, M.Yu, et al. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation. Eur J Pharm Biopharm. 2012;81(2):248–256. doi:10.1016/j.ejpb.2012.03.004.
99. H.Wang, P.Zhao, W.Su, et al. PLGA/polymeric liposome for targeted drug and gene co-delivery. Biomaterials. 2010;31(33):8741–8748. doi:10.1016/j.biomaterials.2010.07.082.
100. S.Aryal, C.M.J.Hu, V.Fu, et al. Nanoparticle drug delivery enhances the cytotoxicity of hydrophobic-hydrophilic drug conjugates. J Mater Chem. 2012;22(3):994–999. doi:10.1039/C1JM13834K.
101. K.Hadinoto, A.Sundaresan, W.S.Cheow. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Eur J Pharm Biopharm. 2013;85(3):427–443. doi:10.1016/j.ejpb.2013.07.002.
102. B.Mandal, N.K.Mittal, P.Balabathula, et al. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer. Eur J Pharm Biopharm. 2015;81:162–171.
103. J.A.Kaplan, R.Liu, J.D.Freedman, et al. Prevention of lung cancer recurrence using cisplatin-loaded superhydrophobic nanofiber meshes. Biomaterials. 2016;76:273–281. doi:10.1016/j.biomaterials.2015.10.060.
104. S.H.Ha, J.H.Hwang, D.H.Kim, et al. Sunitinib release from biodegradable films of poly (L-lactide-co-caprolactone). Mater Res Bul. 2012;47(10):2735–2738. doi:10.1016/j.materresbull.2012.04.125.
105. A.Jhaveri, P.Deshpande, V.Torchilin. Stimuli-sensitive nanopreparations for combination cancer therapy. J Control Release. 2014;190:352–370. doi:10.1016/j.jconrel.2014.05.002.
106. Z.Zhou, X.Ma, E.Jin, et al. Linear-dendritic drug conjugates forming long-circulating nanorods for cancer-drug delivery. Biomaterials. 2010;34(22):5722–5735. doi:10.1016/j.biomaterials.2013.04.012.
107. T.Etrych, L.Kovář, J.Strohalm, et al. Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy. J Control Release. 2011;154(3):241–248. doi:10.1016/j.jconrel.2011.06.015.
108. Q.Xiang, Y.Yang, Z.Zhou, et al. Synthesis and in vitro anti-tumor activity of novel HPMA copolymer-drug conjugates with potential cell surface targeting property for carcinoma cells. Eur J Pharm Biopharm. 2012;80(2):379–386. doi:10.1016/j.ejpb.2011.10.020.
109. O.C.Farokhzad, J.Cheng, B.A.Teply, et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci. 2006;103(16):6315–6320. doi:10.1073/pnas.0601755103.
110. E.K.Park, S.Y.Kim, S.B.Lee, et al. Folate-conjugated methoxy poly (ethylene glycol)/poly (ɛ-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery. J Control Release. 2005;109(1):158–168. doi:10.1016/j.jconrel.2005.09.039.
111. J.Pan, S.S.Feng. Targeted delivery of paclitaxel using folate-decorated poly (lactide)-vitamin E TPGS nanoparticles. Biomaterials. 2008;29(17):2663–2672. doi:10.1016/j.biomaterials.2008.02.020.
112. C.Wang, P.C.Ho, L.Y.Lim. Wheat germ agglutinin-conjugated PLGA nanoparticles for enhanced intracellular delivery of paclitaxel to colon cancer cells. Int J Pharm. 2010;400(1):201–210. doi:10.1016/j.ijpharm.2010.08.023.
113. J.Li, M.Huo, J.Wang, et al. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. Biomaterials. 2012;33(7):2310–2320. doi:10.1016/j.biomaterials.2011.11.022.
114. J.Z.Du, X.J.Du, C.Q.Mao, et al. Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery. J Am Chem Soc. 2011;133(44):17560–17563. doi:10.1021/ja207150n.
115. L.Wu, Y.Zou, C.Deng, et al. Intracellular release of doxorubicin from core-crosslinked polypeptide micelles triggered by both pH and reduction conditions. Biomaterials. 2013;34(21):5262–5272. doi:10.1016/j.biomaterials.2013.03.035.
116. P.Yang, D.Li, S.Jin, et al. Stimuli-responsive biodegradable poly (methacrylic acid) based nanocapsules for ultrasound traced and triggered drug delivery system. Biomaterials. 2014;35(6):2079–2088. doi:10.1016/j.biomaterials.2013.11.057.
117. A.R.G.Sivakumar Balasubramanian, Y.Nagaoka, S.Iwai, et al. Curcumin and 5-fluorouracil-loaded, folate-and transferrin-decorated polymeric magnetic nanoformulation: a synergistic cancer therapeutic approach, accelerated by magnetic hyperthermia. Int J Nanomedicine. 2014;9:437.
118. J.You, R.Shao, X.Wei, et al. Near Infrared Light Triggers Release of Paclitaxel from Biodegradable Microspheres: Photothermal Effect and Enhanced Antitumor Activity. Small. 2010;6(9):1022–1031. doi:10.1002/smll.201000028.
119. Y.Wu, W.Chen, F.Meng, et al. Core-crosslinked pH-sensitive degradable micelles: a promising approach to resolve the extracellular stability versus intracellular drug release dilemma. J Control Release. 2012;164(3):338–345. doi:10.1016/j.jconrel.2012.07.011.
120. S.Han, Y.Liu, X.Nie, et al. Efficient Delivery of Antitumor Drug to the Nuclei of Tumor Cells by Amphiphilic Biodegradable Poly (L-Aspartic Acid-co-Lactic Acid)/DPPE Co-Polymer Nanoparticles. Small. 2012;8(10):1596–1606. doi:10.1002/smll.201102280.
121. A.J.Domb, Z.H.Israel, O.Elmalak, et al. Preparation and characterization of carmustine loaded polyanhydride wafers for treating brain tumors. Pharm Res. 1999;16(5):762–765.
122. G.M.Zentner, R.Rathi, C.Shih, et al. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. J Control Release. 2001;72(1):203–215.
123. C.Boyer, J.Teo, P.Phillips, et al. Effective delivery of siRNA into cancer cells and tumors using well-defined biodegradable cationic star polymers. Mol Pharm. 2013;10(6):2435–2444. doi:10.1021/mp400049e.
124. B.D.Weinberg, H.Ai, E.Blanco, et al. Antitumor efficacy and local distribution of doxorubicin via intratumoral delivery from polymer millirods. J Biomed Mater Res A. 2007;81(1):161–170. doi:10.1002/jbm.a.30914.
125. K.Miller, C.Clementi, D.Polyak, et al. Poly (ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases. Biomaterials. 2013;34(15):3795–3806. doi:10.1016/j.biomaterials.2013.01.052.
126. K.Miller, A.Eldar-Boock, D.Polyak, et al. Antiangiogenic antitumor activity of HPMA copolymer-paclitaxel-alendronate conjugate on breast cancer bone metastasis mouse model. Mol Pharm. 2011;8(4):1052–1062. doi:10.1021/mp200083n.
127. J.Pan, S.S.Feng. Targeting and imaging cancer cells by folate-decorated, quantum dots (QDs)-loaded nanoparticles of biodegradable polymers. Biomaterials. 2009;30(6):1176–1183. doi:10.1016/j.biomaterials.2008.10.039.
128. H.A.Kim, K.Nam, S.W.Kim. Tumor targeting RGD conjugated bio-reducible polymer for VEGF siRNA expressing plasmid delivery. Biomaterials. 2014;35(26):7543–7552. doi:10.1016/j.biomaterials.2014.05.021.